The Effectiveness of Kinesiotaping and Inactivation of Trigger Points in Chronic Myofascial Pain of TMD
KT/TrP/TMD
Evaluation of the Effectiveness of Kinesiotaping and Inactivation of Trigger Points in Chronic Myofascial Pain of Temporomandibular Joint Dysfunction
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
In patients with a long-lasting TMD syndrome, especially of a muscular nature, palpation examination can locate the trigger points of pain (TrP) in the chewing muscles, i.e., the nodules in the shape of bumps the size of rice or pea grains. Kinesiotaping (KT) is considered as an intervention method that can be used to release latent myofascial trigger points. It is a method that involves applying specific tapes to the patient's skin surface in order to use the natural self-healing processes of the body. The aim of the study was to evaluate the effect of Kinesiotaping methods and inactivation of Trigger Points on nonpharmacological elimination of pain in patients with functional disorders of the masticatory motor system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2017
CompletedFirst Submitted
Initial submission to the registry
January 7, 2018
CompletedFirst Posted
Study publicly available on registry
January 12, 2018
CompletedJanuary 16, 2018
January 1, 2018
9 months
January 7, 2018
January 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1. Change from baseline in Visual Analogic Scale
The visual analogic scale allows us to convert subjective sensations as pain on numerical data. A 10cm scale where 0cm is no pain and 10cm the worse imaginable pain, will be used and the subjects will be asked to mark a point on the scale representing their pain. This instrument will be used to compare the VAS values before and after the intervention.
14 days
Other Outcomes (1)
1. Patient Global Impression of Change Scale (PGICS)
3 months
Study Arms (2)
Kinesiotaping
EXPERIMENTALOriginal kinesiotaping active tapes Duration: 2 times Application maintenance 5 days with a break for the weekend Muscle application on the masseter muscle area, using a tape (5 cm wide) dissected into 2 parts called tails, which included the treatment site without their tension.
inactivation of trigger points (TrP)
EXPERIMENTALDuration: 10-20 minutes of surgery; 2 inactivation treatments Between the treatments 5 days break
Interventions
Dynamic adhesive taping is a method that involves the application of specific tapes to the surface of the patient's skin in order to use the natural self-healing processes of the body. It is often used as an element that sustains the therapeutic effect. Its action is based mainly on the action normalizing muscle tone, supporting the work of joints, improving the function of weakened muscles, increasing microcirculation at the site of application.
A procedure for releasing trigger points using physiotherapy using the ischemic compression method, which involves applying pressure to the active trigger point, until it is switched off, i.e. pain ceases.The location of the trigger point is done palpatively, with a pliers grip, covering the strained tissue on the inside and outside of the cheek with the thumb and index finger.
Eligibility Criteria
You may qualify if:
- Age between 18-35 years, both male and female
- Provide informed consent to participate in the study;
- Having a diagnosis of muscular pain TMD(Temporomandibular Disorders) according to group -I A, axis I RDC/TMD(Research Diagnostic Criteria)
- Visual analogic scale (VAS) score from 4 to 10 for 14 days
- Not have history of alcohol or drugs abuse within the past 6 months as self-reported
- Not use ot carbamazepine (or similar) within the past 6 months as self reported
- Not have history of neurosurgery as self-reported
- Not have history of major psychiatric disorders such as schizophrenia and bipolar disorder
- Not have any other previously diagnosed disorder with symptoms similar to the TMD, such as fibromyalgia.
You may not qualify if:
- One absence during therapeutic sessions;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pomeranian Medical University Szczecinlead
- Ministry of Health, Polandcollaborator
Study Officials
- STUDY DIRECTOR
Edward S Kijak, DSc
Pomeranian Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 7, 2018
First Posted
January 12, 2018
Study Start
October 2, 2016
Primary Completion
June 15, 2017
Study Completion
September 30, 2017
Last Updated
January 16, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share